Literature DB >> 33554216

FOXP1 Interacts with MyoD to Repress its Transcription and Myoblast Conversion.

Woodring E Wright1, Chuan Li2, Chang-Xue Zheng3, Haley O Tucker3.   

Abstract

Forkhead transcription factors (TFs) often dimerize outside their extensive family, whereas bHLH transcription factors typically dimerize with E12/E47. Based on structural similarities, we predicted that a member of the former, Forkhead Box P1 (FOXP1), might heterodimerize with a member of the latter, MYOD1 (MyoD). Data shown here support this hypothesis and further demonstrate the specificity of this forkhead/myogenic interaction among other myogenic regulatory factors. We found that FOXP1-MyoD heterodimerization compromises the ability of MyoD to bind to E-boxes and to transactivate E box- containing promoters. We observed that FOXP1 is required for the full ability of MyoD to convert fibroblasts into myotubules. We provide a model in which FOXP1 displaces ID and E12/E47 to repress MyoD during the proliferative phase of myoblast differentiation. These data identify FOXP1 as a hitherto unsuspected transcriptional repressor of MyoD. We suggest that isolation of paired E-box and forkhead sites within 1 turn helical spacings provides potential for cooperative interactions among heretofore distinct classes of transcription factors.

Entities:  

Keywords:  Forkhead box P1; Myoblast differentiation; Myogenic regulatory factors; Transcriptional regulation

Year:  2021        PMID: 33554216      PMCID: PMC7861563     

Source DB:  PubMed          Journal:  J Cell Signal


  72 in total

1.  Functional activity of myogenic HLH proteins requires hetero-oligomerization with E12/E47-like proteins in vivo.

Authors:  A B Lassar; R L Davis; W E Wright; T Kadesch; C Murre; A Voronova; D Baltimore; H Weintraub
Journal:  Cell       Date:  1991-07-26       Impact factor: 41.582

Review 2.  The circuitry of a master switch: Myod and the regulation of skeletal muscle gene transcription.

Authors:  Stephen J Tapscott
Journal:  Development       Date:  2005-06       Impact factor: 6.868

3.  Muscle-specific transcriptional activation by MyoD.

Authors:  H Weintraub; V J Dwarki; I Verma; R Davis; S Hollenberg; L Snider; A Lassar; S J Tapscott
Journal:  Genes Dev       Date:  1991-08       Impact factor: 11.361

4.  Cooperative regulation in development by SMRT and FOXP1.

Authors:  Kristen Jepsen; Anatoli S Gleiberman; Can Shi; Daniel I Simon; Michael G Rosenfeld
Journal:  Genes Dev       Date:  2008-03-15       Impact factor: 11.361

5.  Genome-wide identification of enhancers in skeletal muscle: the role of MyoD1.

Authors:  Roy Blum; Vasupradha Vethantham; Christopher Bowman; Michael Rudnicki; Brian D Dynlacht
Journal:  Genes Dev       Date:  2012-12-15       Impact factor: 11.361

6.  A role for histone deacetylase HDAC1 in modulating the transcriptional activity of MyoD: inhibition of the myogenic program.

Authors:  A Mal; M Sturniolo; R L Schiltz; M K Ghosh; M L Harter
Journal:  EMBO J       Date:  2001-04-02       Impact factor: 11.598

7.  Strategies to Study Desmin in Cardiac Muscle and Culture Systems.

Authors:  Antigoni Diokmetzidou; Mary Tsikitis; Sofia Nikouli; Ismini Kloukina; Elsa Tsoupri; Stamatis Papathanasiou; Stelios Psarras; Manolis Mavroidis; Yassemi Capetanaki
Journal:  Methods Enzymol       Date:  2015-11-03       Impact factor: 1.600

8.  MyoD binds cooperatively to two sites in a target enhancer sequence: occupancy of two sites is required for activation.

Authors:  H Weintraub; R Davis; D Lockshon; A Lassar
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

9.  The E12 inhibitory domain prevents homodimer formation and facilitates selective heterodimerization with the MyoD family of gene regulatory factors.

Authors:  M Shirakata; B M Paterson
Journal:  EMBO J       Date:  1995-04-18       Impact factor: 11.598

10.  Twist2 amplification in rhabdomyosarcoma represses myogenesis and promotes oncogenesis by redirecting MyoD DNA binding.

Authors:  Stephen Li; Kenian Chen; Yichi Zhang; Spencer D Barnes; Priscilla Jaichander; Yanbin Zheng; Mohammed Hassan; Venkat S Malladi; Stephen X Skapek; Lin Xu; Rhonda Bassel-Duby; Eric N Olson; Ning Liu
Journal:  Genes Dev       Date:  2019-04-11       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.